Barostim and the Window of Opportunity in Class II/III HFrEF Patients HFSA Symposium 2023 Discussion
Hear discussion and insights from Drs. Dmitry Yaranov, William T. Abraham, Gurusher Panjrath, and Patrick McCann following the HFSA 2023 symposium.
Login to view comments.
Click here to Login
